Saccharomyces boulardii (Sb) is a widely used fungal probiotic in treating various digestive
diseases, including irritable bowel syndrome (IBS). However, the specific mechanisms of Sb …

Recent clinical studies have demonstrated a beneficial effect of Saccharomyces boulardii (S.
boulardii) in inflammatory bowel disease (IBD). However, the underlying mechanisms …

Background The role that probiotics play in relieving irritable bowel syndrome (IBS) has
been demonstrated; however, the mechanism by which IBS is affected remains unclear. In …

The purpose of this study is to investigate the mitigatory effect of a novel synbiotic (SBT) on
constipation from the perspective of gut microbiome and metabolome. Here, intake of SBT …

Irritable bowel syndrome (IBS) is a functional intestinal disorder without clear pathological
mechanisms. Classical treatments for IBS are not always effective and are usually …

Growing evidence shows that gut microbes are key factors involved in the regulation of
energy homeostasis, metabolic inflammation, lipid metabolism, and glucose metabolism …

The probiotic Saccharomyces boulardii has been widely used in colitis treatment; however,
the beneficial effects of other yeast species are rarely studied. Saccharomyces cerevisiae …

Gut microbiota and short‐chain fatty acids (SCFAs) are associated with the development of
various human diseases. In this study, we examined the role of astragaloside IV in …

Probiotics have received widespread attention as a healthy ingredient. The preventive effect
of Bifidobacterium lactis TY-S01 on loperamide-induced constipation in mice was …

Background Gnotobiotic mice colonized with microbiota from patients with irritable bowel
syndrome (IBS) and comorbid anxiety (IBS+ A) display gut dysfunction and anxiety‐like …